Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody
Abstract Background Dysregulated production of interleukin (IL)-6 is implicated in the pathology of inflammatory bowel disease (IBD). Neutralization of IL-6 in the gut by safe probiotic bacteria may help alleviate intestinal inflammation. Here, we developed Lactococcus lactis with potent and selecti...
Na minha lista:
| Principais autores: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2022-07-01
|
| 叢編: | Microbial Cell Factories |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1186/s12934-022-01873-7 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|